Survival following the onset of scleroderma: Results from a retrospective inception cohort study of the UK population

British Journal of Rheumatology

Volumn 35, Issue 11, 1996, Pages 1122-1126

  Bryan, C ^a   Howard, Y ^b   Brennan, P ^a   Black, C ^b   Silman, A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Mortality; Scleroderma; Survival

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCLERODERMA; SEX RATIO; SURVIVAL; UNITED KINGDOM;

COHORT STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MALE; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SURVIVAL RATE;

EID: 0029910577     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Black CM, Stephens C. Systemic sclerosis (scleroderma) and related disorders. In Maddison PJ, Isenberg DA, Woo P, Glass DN, eds. Oxford textbook of rheumatology. Oxford: Oxford University Press, 1993, pp. 771-89.
2. Silman AJ. Scleroderma and survival: A review. Ann Rheum Dis 1990;50:267-9.
3. Altman RD, Medsger TA, Bloch DA, Michel BA. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991;34:403-13.
4. Lee P, Langevitz P, Alderdice CA et al. Mortality in systemic sclerosis (scleroderma). Q J Med 1992;82:139-48.
5. Hay E, Croft PC. Predicting outcome in current clinic attenders: A biased View. Ann Rheum Dis 1994;53:357-8.
6. Silman AJ, Jannini S, Symmons D, Bacon P. An epidemiologic study of scleroderma in the West Midlands. Br J Rheumatol 1988;27:286-90.
7. Abu-Shakra M, Lee P. Mortality in systemic sclerosis: A comparison with the general population. J Rheumatol 1995;22:2100-2.
8. Masi AT, Rodnan GP, Medsger TA et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
9. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. Br J Rheumatol 1988;15:202-5.
10. Office of Population Censuses & Surveys. Mortality statistics by area, England & Wales. Series DH 5 No. 17. London: HMSO, 1990.
11. Medsger TA, Masi AT, Rodnan GP, Benedek TG, Robinson H. Survival with systemic sclerosis (scleroderma): A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971;75:369-76.
12. Roumm AD, Medsger TA. Cancer and systemic sclerosis. Arthritis Rheum 1985;28:1336-40.
13. Abu-Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993;36:460-4.
14. Rosenthal AK, McLaughlin JK, Linet MS, Persson I. Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 1993;52:531-3.
15. Barnett AJ, Miller MH, Littlejohn GO. A survival of patients with scleroderma diagnosed over 30 years (1950-1983): The value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 1988;15:276-83.
16. Veale DJ, Collidge TA, Belch JJF. Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis 1995;54:853-5.
17. Ingemar B, Lindahl B. In what sense is rheumatoid arthritis the principal cause of death? A study of the National Statistics Office's way of reasoning based on 1224 death certificates. J Chron Dis 1985;38:963-72.
18. Bennett R, Bluestone R, Holt PJL, Bywaters EGL. Survival in scleroderma. Ann Rheum Dis 1971;30:581-8.
19. Rowell NR. The prognosis of systemic sclerosis. Br J Dermatol 1976;29:57-60.